Clinical Trial Update: A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating roxadustat for anemia in chronic kidney disease patients not on dialysis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Anemia

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: CKD Anemia | Phase 3 | Status: COMPLETED | Results posted: 2021-10-01